ReiThera
Rome, IT
1 confirmed programs
· 1 sponsors
· Last scored 2026-04-02
71.1
Signal Score
○ FDA Inspections
✓ Clinical Trials (1)
○ SEC Filings
○ Press
✓ EMA GMP (4)
○ MHRA GMP
Quick Facts: ReiThera
- Signal Score
- 71.1/100 (as of 2026-04-02)
- Quality Compliance
- 100.0/100 — No FDA inspection records found for this manufacturer
- Headquarters
- Rome, IT
- Modalities
- Adenoviral, AAV
- Active Programs
- 1 confirmed from ClinicalTrials.gov across 1 sponsors
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
Signal Score & Pillar Breakdown
Quality Compliance
100.0
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Source: FDA Data Dashboard
No FDA inspection records found for this manufacturer · Quality score requires FDA inspection data
FDA InspectionsNo US records on file
EMA GMP Certificates4 on record
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
50.0
1 active programs across 1 sponsors
Modalities: AAV, Adenoviral
Source: ClinicalTrials.gov
1 active programs across 1 sponsors · Modalities: AAV, Adenoviral
Programs
1
Sponsors1
ModalitiesAdenoviral, AAV
1 active programs across 1 sponsors
Modalities: AAV, Adenoviral
Source: ClinicalTrials.gov facility matching
Source: ClinicalTrials.gov · Retrieved Apr 05, 2026
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
58.0
1 manufacturing site: Rome, Italy
Modalities: Adenoviral, AAV
Capacity assessment: 58.0/100
Sites: Rome, Italy
Source: SEC EDGAR, press monitoring, company profiles
1 manufacturing site
1 manufacturing site: Rome, Italy
Modalities: Adenoviral, AAV
Capacity assessment: 58.0/100
EMA GMP Compliance 4 certificates
2024-11
2024-11
2022-01
2022-01
Compliant
Non-Compliant
| Certificate | Site | Country | Inspection Date | Status |
|---|---|---|---|---|
| IT/44/H/2025 | Reithera S.r.l. | Italy | 2024-11-22 | COMPLIANT |
| IT-API/32/H/2025 | Reithera S.r.l. | Italy | 2024-11-22 | COMPLIANT |
| IT-API/119/H/2022 | Reithera S.r.l. | Italy | 2022-01-28 | COMPLIANT |
| IT-API/251/H/2022 | Reithera S.r.l. | Italy | 2022-01-28 | COMPLIANT |
Source: EMA EudraGMDP · Retrieved Apr 05, 2026
Clinical Activity 1 studies
Source: ClinicalTrials.gov · Retrieved Apr 05, 2026
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Thermo Fisher Scientific
Plainville, MA · Alachua, FL · Cambridge, MA
Signal Score: 83.2
AAV, Lentiviral, Plasmid DNA, Adenoviral
Exothera
Jumet, BE
Signal Score: 78.1
AAV, Adenoviral, Lentiviral
Advent Bioservices
London, UK
Signal Score: 78.1
AAV, Lentiviral, Adenoviral
Vigene Biosciences
Rockville, MD
Signal Score: 72.5
AAV, Lentiviral, Adenoviral
Emergent BioSolutions (CGT)
Baltimore, MD
Signal Score: 71.0
AAV, Adenoviral